The Institute for Safe Medication Practices performs a watchdog function when it comes to monitoring errors in prescribing and administering drugs throughout the U.S. healthcare system. It recently reported that one hospital has had to test 4,200 patients after learning that they may have received insulin injections from insulin pens previously used on other patients.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) indicates that brief bursts of intense exercise before meals (termed exercise ‘snacking’ by the study authors) helps control blood sugar in people with insulin resistance more effectively than one daily 30-minute session of moderate exercise.
The new study, which will be published online May 7 in Diabetes Care, coupled a glucose sensor worn under the skin to an insulin pump that was connected wirelessly to a computer at the bedside. The computer ran an algorithm that calculated when a low blood-sugar level might occur and then temporarily suspended insulin delivery […]
The Food and Drug Administration (FDA) has delayed until July 15th whether to allow the inhaled insulin Afrezza entry into the American market.
Glucovation out of Carlsbad, California, a new company founded by former Dexcom engineers, has developed the SugarSenz continuous glucose monitor. Much like devices for diabetics, it sticks onto the abdomen and penetrates the skin to receive regular samples of blood for testing. The company claims it will not require calibration using blood from finger pricks.
A threshold level of 25-hydroxyvitamin D may exist with potential benefits on glycemic control. Vitamin D supplementation is a common practice throughout the United States. Levels of 25-hydroxyvitamin D, 25(OH)D, that are considered normal are based upon guidelines established primarily from bone metabolism studies.
The small 16-year-old startup is developing an implantable CGM dubbed ICGM, which in its second incarnation uses a sensor that looks like a fat thumb drive with a quarter-sized circle in the middle.
Data from the independent investigator-initiated HypoAna study published in The Lancet Diabetes & Endocrinology, shows that Novo Nordisk’s short-acting and long-acting modern insulin analogues NovoRapid® (insulin aspart) and Levemir® (insulin detemir) significantly reduce severe hypoglycaemia in people with type 1 diabetes compared to human insulin (regular/NPH).
Essentially, we at the ‘Mine believe that people with diabetes are at a disadvantage as consumers – after all, where can we patients post and explore user reviews of products aimed at our chronic disease care, like other consumers can do for any variety of products? We aim to remedy that with this new video […]
Hospitals are supposed to be places to heal, but they can also become hotbeds of infection if proper rules of hygiene aren’t being followed. Unfortunately, insulin-dependent people with diabetes are some of the most at risk of danger when these rules break down.
The primary endpoint of this study was the reduction in HbA1c from baseline at 12 months. Secondary outcomes included insulin therapy intensification in response to higher blood glucose levels (determined by elevated Hb1Ac or elevated urinary glucose).
Admani expects the UniStrip1 strips to be marketed for about $15 per 50-count box or less, compared to the current cost of $50 or $60 per vial. The strips are compatible with the OneTouch Ultra, Ultra2, UltraSmart and UltraMini meters.
Acute oscillations in blood glucose are associated with negative outcomes in diabetes. Many believe such oscillations may be a significant risk factor for diabetes complications beyond the average glycemic exposure.
The HDV compound would be injected or swallowed as a pill where it would attach to insulin, causing the insulin to be better absorbed into the liver’s metabolic cells before being released back into the bloodstream. In short, this could be an insulin delivery game-changer.
If you have a high blood sugar during meal time and you use matching insulin to carbohydrate as your method of dosing insulin, you should be able to use your correction factor to cover the high blood sugar and then give the appropriate dose of insulin for the meal.
Afternoon moderate-to-vigorous physical activity (MVPA) increases the risk of overnight and next-day hypoglycemia in adolescents with type 1 diabetes, according to research published in the May issue of Diabetes Care.
There’s a lot of novel work happening in the diabetes research world on new types of glucagon, from Epi-Pen delivery devices to work on stable forms that could be used in infusion pumps along with insulin
Insulin prescription errors rank first among all prescribed drugs. In an effort to remedy this problem, Eli Lilly is developing a prefilled pen for delivering Humulin R U-500 insulin as well as collaborating on the development of a dedicated U-500 syringe.
The system makes a huge stride in making it easier to quickly download glucose data, analyze it, and make some diabetes management changes using your smartphone. The Verio Sync’s accompanying app – OneTouch Reveal – is the major highlight of the system.
Cleveland-based Thermalin said today that JDRF will provide it with up to $1 million for specific milestones related to identifying a clinical candidate insulin analog with a shorter tail of action.